P.0463 Phase 1 open-label study assessing the pharmacokinetics and safety of TV-46000, a novel long-acting subcutaneous injectable formulation of risperidone

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2021.10.436 ◽

2021 ◽

Vol 53 ◽

pp. S339-S340

Author(s):

A. Merenlender Wagner ◽

A. Elgart ◽

I. Perlstein ◽

M. Lamson ◽

R. Tiver ◽

...

Keyword(s):

Phase 1 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Injectable Formulation ◽

Long Acting

Download Full-text

Biochemical control was sustained with long-acting pasireotide in patients with uncontrolled acromegaly over continued treatment with first-generation somatostatin analogues (SSAs): Results from the extension of phase 3b, open-label study

Endocrine Abstracts ◽

10.1530/endoabs.63.gp57 ◽

2019 ◽

Author(s):

Monica Gadelha ◽

Annamaria Colao ◽

Marie Bex ◽

Rishav Mukherjee ◽

Catherine Bourad ◽

...

Keyword(s):

First Generation ◽

Somatostatin Analogues ◽

Biochemical Control ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Long Acting

Download Full-text

Phase 1 First Time in Humans (FTIH), Open Label Study of GSK3745417 Administered to Subjects With Advanced Solid Tumors

Case Medical Research ◽

10.31525/ct1-nct03843359 ◽

2000 ◽

Author(s):

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

First Time

Download Full-text

Phase 1 open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of dilpacimab in patients with advanced solid tumors

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-20-0985 ◽

2021 ◽

pp. molcanther.0985.2020

Author(s):

Michael S. Gordon ◽

John Nemunaitis ◽

Minal Barve ◽

Zev A. Wainberg ◽

Erika P. Hamilton ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Advanced Solid Tumors ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Journal of Hematology & Oncology ◽

10.1186/s13045-018-0681-6 ◽

2018 ◽

Vol 11 (1) ◽

Cited By ~ 125

Author(s):

Wan-Hong Zhao ◽

Jie Liu ◽

Bai-Yan Wang ◽

Yin-Xia Chen ◽

Xing-Mei Cao ◽

...

Keyword(s):

Multiple Myeloma ◽

Cell Therapy ◽

Phase 1 ◽

Cell Maturation ◽

Open Label ◽

T Cell Therapy ◽

Open Label Study ◽

Label Study ◽

B Cell Maturation ◽

B Cell Maturation Antigen

Download Full-text

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s79347 ◽

2015 ◽

pp. 1349 ◽

Cited By ~ 3

Author(s):

Ernie Anand ◽

Lovisa Berggren ◽

Claudia Deix ◽

Ágoston Tóth ◽

David McDonnell

Keyword(s):

Efficacy And Safety ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Post Hoc Analysis ◽

Long Acting ◽

Post Hoc

Download Full-text

Single‐ and multiple‐dose pharmacokinetics and safety of pimodivir, a novel, non‐nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open‐label study in healthy volunteers

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13733 ◽

2018 ◽

Vol 84 (11) ◽

pp. 2663-2672 ◽

Cited By ~ 6

Author(s):

Sofie Deleu ◽

Thomas N. Kakuda ◽

Kurt Spittaels ◽

Jurgen J. Vercauteren ◽

Vera Hillewaert ◽

...

Keyword(s):

Healthy Volunteers ◽

Influenza A Virus ◽

Influenza A ◽

Multiple Dose ◽

Basic Protein ◽

Phase 1 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Multiple Dose Pharmacokinetics

Download Full-text

ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS

Neuro-Oncology ◽

10.1093/neuonc/noy148.073 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi20-vi20

Author(s):

Daniela A Bota ◽

Santosh Kesari ◽

David Piccioni ◽

Dawit Aregawi ◽

Patrick Roth ◽

...

Keyword(s):

Malignant Glioma ◽

Phase 1 ◽

Newly Diagnosed ◽

Open Label ◽

Who Grade ◽

Open Label Study ◽

Label Study

Download Full-text

Abstract C37: A Phase 1 open‐label study evaluating pharmacokinetics, safety, and tolerability of linifanib in Japanese patients with solid tumors

10.1158/1535-7163.targ-09-c37 ◽

2009 ◽

Author(s):

Tomohide Tamura ◽

Noboru Yamamoto ◽

Hiroshi Nokihara ◽

Yasuhide Yamada ◽

Hajime Asahina ◽

...

Keyword(s):

Solid Tumors ◽

Phase 1 ◽

Japanese Patients ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

P.3.c.011 Olanzapine long-acting injection vs oral olanzapine in schizophrenia outpatients: a 2-year, randomized, open-label study

European Neuropsychopharmacology ◽

10.1016/s0924-977x(10)70681-7 ◽

2010 ◽

Vol 20 ◽

pp. S464 ◽

Cited By ~ 3

Author(s):

H. Detke ◽

P.J. Weiden ◽

T. Lambert ◽

P.M. Llorca ◽

M. Choukour ◽

...

Keyword(s):

Open Label ◽

Open Label Study ◽

Label Study ◽

Oral Olanzapine ◽

Long Acting

Download Full-text

A phase 1/2 open-label study of safety and antitumor activity of EPI-506, a novel AR N-terminal domain inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC) with progression after enzalutamide or abiraterone.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps5072 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS5072-TPS5072 ◽

Cited By ~ 14

Author(s):

Robert B. Montgomery ◽

Emmanuel S. Antonarakis ◽

Maha Hussain ◽

Karim Fizazi ◽

Anthony M. Joshua ◽

...

Keyword(s):

Prostate Cancer ◽

Antitumor Activity ◽

Phase 1 ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Terminal Domain ◽

Castration Resistant

Download Full-text